Montag & Associates’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.3K Sell
320
-48
-13% -$3.36K ﹤0.01% 684
2026
Q1
$28K Sell
368
-55
-13% -$3.92K ﹤0.01% 650
2025
Q4
$26.3K Buy
423
+320
+311% +$18.8K ﹤0.01% 669
2025
Q3
$6.09K Hold
103
– – ﹤0.01% 804
2025
Q2
$6.05K Buy
103
+47
+84% +$2.66K ﹤0.01% 787
2025
Q1
$2.8K Buy
+56
New +$2.87K ﹤0.01% 874
2023
Q1
– Sell
-19
Closed -$1.4K – 950
2022
Q4
$1.4K Hold
19
– – ﹤0.01% 885
2022
Q3
$2K Hold
19
– – ﹤0.01% 815
2022
Q2
$2K Hold
19
– – ﹤0.01% 771
2022
Q1
$2K Buy
+19
New +$1.57K ﹤0.01% 785
2021
Q1
– Sell
-60
Closed -$3K – 883
2020
Q4
$3K Buy
+60
New +$2.65K ﹤0.01% 758

Other funds holding NTR

Montag & Associates's NTR Position: Q2 2026 in Review

Montag & Associates reduced its Nutrien (NTR) stake by 13% in Q2 2026, selling an estimated $3.36K and leaving 320 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #684.

Montag & Associates first reported a position in NTR in Q4 2020 and has held it in 11 quarters since. The position peaked at $28K in Q1 2026. 734 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Montag & Associates held 320 shares of Nutrien worth $20.3K as of Q2 2026.
  • Montag & Associates sold 48 Nutrien shares in Q2 2026, an estimated $3.36K.
  • Nutrien made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #684 holding.
  • Montag & Associates first reported a position in Nutrien in Q4 2020 and has held it in 11 quarters since.
  • Montag & Associates's Nutrien position peaked at $28K in Q1 2026.
  • 734 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.